Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial. J Med Internet Res (2017) 0.75

Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99

EQ-5D: a measure of health status from the EuroQol Group. Ann Med (2001) 18.69

Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol (2008) 4.78

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol (2013) 3.87

Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med (2012) 3.86

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68

Validating the EQ-5D with time trade off for the German population. Eur J Health Econ (2005) 2.65

Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59

Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol (2015) 1.73

Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life. Dtsch Arztebl Int (2010) 1.64

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J Pain Symptom Manage (2010) 1.39

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer (2005) 1.37

Self-assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires. Ann Rheum Dis (2008) 1.19

Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J (2013) 1.18

Impact of chemotherapy beyond the first line in patients with metastatic breast cancer. Breast Cancer Res Treat (2007) 1.16

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer (2010) 1.09

Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making. J Clin Oncol (2007) 1.06

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast (2012) 0.99

Goals of treatment for patients with metastatic breast cancer. Semin Oncol (2006) 0.96

Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. BMC Cancer (2004) 0.96

Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval. BMJ Open (2015) 0.88

Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat (2010) 0.87

Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients. Psychooncology (2009) 0.87

2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol (2008) 0.86

[The benefits of using patient-reported outcomes in cancer treatment: an overview]. Wien Klin Wochenschr (2012) 0.85

[What information do people needing care and their care-giving relatives need?]. Z Gerontol Geriatr (2010) 0.85

Tablet, web-based, or paper questionnaires for measuring anxiety in patients suspected of breast cancer: patients' preferences and quality of collected data. J Med Internet Res (2014) 0.83

[Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study]. Psychother Psychosom Med Psychol (2013) 0.82

Chemotherapy for Metastatic Breast Cancer - An Anachronism in the Era of Personalised and Targeted Oncological Therapy? Geburtshilfe Frauenheilkd (2015) 0.79

[Why Strive after Clinical Social Medicine? From Epidemiological Association to Personalized Social Medicine: a Case of Breast Cancer Care]. Gesundheitswesen (2016) 0.78

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network. Geburtshilfe Frauenheilkd (2015) 0.78

Metastatic breast cancer survival according to HER2 and Topo2a gene status. Dis Markers (2009) 0.77

[Diagnosis and treatment of breast cancer]. Chirurg (2005) 0.77